We are live on ! Find out more
ARAV

Aravive, Inc. Common Stock

Delisted

ARAV was delisted on the 26th of January, 2024.

37 hedge funds and large institutions have $10.1M invested in Aravive, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 3637 (+1)

1% more capital invested

Capital invested by funds: $9.99M → $10.1M (+$118K)

63% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 16

Holders
37
Holders Change
+1
Holders Change %
+2.78%
% of All Funds
0.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
6
Reduced
16
Closed
4
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
+$6K

ARAV Hedge Fund Activity: Q1 2022 in Review

37 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q1 2022, worth a combined $10.1M — up 1.2% from $9.99M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ARAV positions and 4 closed out — a net gain of 1 holder — while 6 added to existing stakes and 16 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $2.01M. The largest seller was Renaissance Technologies, cutting an estimated $139K.

  • 37 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q1 2022, up from 36 in Q4 2021.
  • Funds reported $10.1M of Aravive, Inc. Common Stock stock for Q1 2022, up 1.2% quarter-over-quarter.
  • 5 funds opened new Aravive, Inc. Common Stock positions in Q1 2022 and 4 closed out, a net change of +1 holder.
  • The largest Aravive, Inc. Common Stock buyer in Q1 2022 was Armistice Capital, an estimated $2.01M added.
  • The largest Aravive, Inc. Common Stock seller in Q1 2022 was Renaissance Technologies, an estimated $139K sold.

Based on aggregated 13F filings for Q1 2022.